Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 232 results for "esbl"

Carriage Rates and Characteristics of Enterobacteriaceae Produ...

Aims: We compared the prevalence of extended-spectrum beta-lactamase (ESBL) producers in the faecal samples of 1,109 healthy individuals screened for employment purposes and in 531 asymptomatic individuals applying for long-term care (LTC). Methods: ... Karger.com, 2 weeks ago

Rapid Detection in Blood Cultures of ESBL-Producing Enterobacteriaceae

Image: The BacT/ALERT 3D Dual-T apparatus for microbial detection (Photo courtesy of bioMérieux). Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) technology has been used directly with blood cultures ...
 Lab Medica2 months ago

Recent Studies from CIBERESP Add New Data to Escherichia coli [Molecular Characterization and Genetic Diversity of ESBL-Producing Escherichia coli...

Recent Studies from CIBERESP Add New Data to Escherichia coli [Molecular Characterization and Genetic Diversity of ESBL-Producing Escherichia coli Colonizing the Migratory Franklin's Gulls (Leucophaeus pipixcan) in Antofagasta , North of Chile ] ...
 4 Traders2 months ago
Monthly Prescribing Reference

Actavis Launches AVYCAZ? Ceftazidime-Avibactam Anti-Infective In U.S.

By a News Reporter-Staff News Editor at Clinical Trials Week Actavis plc (NYSE: ACT) announced AVYCAZ? (ceftazidime-avibactam) is now available for ordering by hospitals across the United States. AVYCAZ is indicated for the treatment of adult ...
 Pharmacy Choice1 day ago Actavis announces availability of anti-bacterial drug in US  Individual.com4 days ago ACTAVIS : Launches AVYCAZ Ceftazidime-Avibactam Anti-Infective In U.S.  4 Traders5 days ago New Antibiotic Available for Serious Infections  Monthly Prescribing Reference1 week ago
[x]  

Sudbury's Ronald Romanko shares story of battle with drug-resistant bug

WhenRonald Romanko went to the Sudbury hospital for a precautionaryprostate biopsy in September he never imagined he would spend the next three weeks there. He ended up hospitalizedfighting an antibiotic-resistant infection caused by ...
 CBC4 days ago

Cargo Ship on the Way to the International Space Station Hurtling Back to Earth at 17,000 MPH

What to read next "},{"id":"b0c8d500-ee9f-11e4-9f13-db73bc55bb29","source":"listSlideshow","type":"slideshow","title":"Photos of the day - April 29, ...
 Yahoo! News5 days ago

OpGen's Acuitas(R) MDRO Gene Test Data Presented at 25th European Congress of Clinical Microbiology and Infectious Diseases

(GLOBE NEWSWIRE) -- OpGen, Inc., a molecular testing and bioinformatics company, today announced that new study data on its Acuitas® MDRO Gene Test was presented at the 25 th European Congress of Clinical Microbiology and Infectious Diseases ...
 Vision Monday5 days ago
[x]  

Merck Announces Publication of Pivotal Data from Phase 3 Clinical Studies of ZERBAXA (Ceftolozane/Tazobactam) in The Lancet and Clinical Infectious Diseases

Merck ( NYSE:MRK ), known as MSD outside the United States and Canada, today announced that The Lancet and Clinical Infectious Diseases have published online the results from the pivotal Phase 3 clinical studies of ZERBAXA ...
 Franklin Credit Management Corporation1 week ago Merck & Co. Announces Publication Of Pivotal Data From Phase 3 Clinical Studies Of ZERBAXA (Ceftolozane/Tazobactam) In The Lancet And /i>  BioSpace6 days ago MERCK : Announces Publication of Pivotal Data from Phase 3 Clinical Studies of ZERBAXA (Ceftolozane/Tazobactam) in The Lancet and Clinical Infectious Diseases  4 Traders1 week ago
[x]  

This Tetraphase Pharma Analyst Expects Positive Data In Mid-2015

In a report published Tuesday, analysts at Brean Capital maintained their Buy rating on Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH). The price target was also maintained at $50. The analysts expect the company to post positive IGNITE 2 data in ...
 Benzinga.com1 week ago

TetraPhase Pharmaceuticals's Eravacycline Meets Primary Endpoint In Phase III Study

Tetraphase Pharmaceuticals Presents Detailed Results From Phase 3 Trials of Eravacycline at 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) WATERTOWN, Mass., April 27, 2015 (GLOBE NEWSWIRE) -- Tetraphase ...
 BioSpace1 week ago Tetraphase Pharmaceuticals Presents Detailed Results From Phase 3 Trials of Eravacycline at 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)  Securities Technology Monitor1 week ago Tetraphase presents detailed results from Phase 3 trials of eravacycline  Drug Discovery News1 week ago Tetraphase Pharmaceuticals : Presents Detailed Results From Phase 3 Trials of Eravacycline at 25th European Congress of Clinical Microbiology and...  4 Traders1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less